Group 1 - Company Asia-Pacific Holdings received a notification from a major domestic automotive group to supply rear brake caliper assemblies for its new energy vehicle platform, with a project lifecycle of 6 years and expected sales of approximately 360 million yuan [1] - Company Fuyuan Pharmaceutical obtained a drug registration certificate for Axomoxifene capsules, which are used to treat hypertriglyceridemia and hypercholesterolemia, indicating successful consistency evaluation [1] - Company Beizhi Technology signed a strategic cooperation agreement with Beijing Xingdong Jiyuan Technology Co., focusing on humanoid robots in smart logistics applications [1] Group 2 - Company Suhao Hongye's subsidiary received land storage compensation of 5.324 million yuan, totaling 30.648 million yuan in compensation by June 10, 2025 [3] - Company Tiankang Biological reported a 9.67% year-on-year decline in pig sales in May, with sales revenue of 345 million yuan, down 19.95% year-on-year [5] - Company Bichang Pharmaceutical's subsidiary received a drug registration certificate for Adalimumab injection, which is indicated for rheumatoid arthritis and ankylosing spondylitis [7] Group 3 - Company Yuyuan Communication's application for A-share issuance was accepted by the Shanghai Stock Exchange, indicating readiness for capital market activities [20] - Company Chengdu Huami released a high-precision RF ADC chip, which is expected to be widely used in radar, 6G wireless communication, and high-end medical equipment [21] - Company Xiantan Co. reported a 14.22% year-on-year increase in chicken product sales revenue in May, reaching 469 million yuan [23] Group 4 - Company Zeyun New Energy plans to apply for a comprehensive credit limit of up to 1.2 billion yuan from banks [29] - Company Kanghong Pharmaceutical's subsidiary used approximately 164.5 million yuan of its own funds to purchase financial products [30] - Company Hainan Development intends to acquire 51% of Wangying Technology for 438 million yuan [53]
6月10日晚间重要公告一览